Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 2278-2287

  Ren, Shancheng ^a   Liu, Yawei ^b   Xu, Weidong ^a   Sun, Yi ^a   Lu, Ji ^a   Wang, Fubo ^a   Wei, Min ^a   Shen, Jian ^a   Hou, Jianguo ^a   Gao, Xu ^a   Xu, Chuanliang ^a   Huang, Jiaoti ^d   Zhao, Yi ^c   Sun, Yinghao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese PLA   (China)

^c Advanced Computer Research Center   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiandrogens; MALAT1 long non coding RNA, human; Prostate; Prostatic neoplasms; RNA, small interfering

Indexed keywords

LONG UNTRANSLATED RNA; MALAT 1 PROTEIN; PROSTATE SPECIFIC ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CASTRATION RESISTANT PROSTATE CANCER; CELL COUNT; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; FLOW CYTOMETRY; GLEASON SCORE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 84888640327     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.07.001     Document Type: Article

References (29)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013;63:11.
2. Roberts WB and Han M: Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer. Surg Oncol 2009;18:268.
3. Han M, Partin AW, Pound CR et al: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin N Am 2001;28:555.
4. Scher HI and Sawyers CL: Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005;23:8253.
5. Clarke NW: Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer. BJU Int, suppl 2012;110:14.
6. Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10:155.
7. Gibb EA, Brown CJ and Lam WL: The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011;10:38.
8. Carninci P, Kasukawa T, Katayama S et al: The transcriptional landscape of the mammalian genome. Science 2005;309:1559.
9. Cheng J, Kapranov P, Drenkow J et al: Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005;308:1149.
10. Amaral PP and Mattick JS: Noncoding RNA in development. Mamm Genome 2008;19:454.
11. Orom UA and Shiekhattar R: Long non-coding RNAs and enhancers. Curr Opin Genet Dev 2011;21:194.
12. Dinger ME, Amaral PP, Mercer TR et al: Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 2008;18:1433.
13. Rinn JL, Kertesz M, Wang JK et al: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311.
14. Pibouin L, Villaudy J, Ferbus D et al: Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 2002;133:55.
15. Fu X, Ravindranath L, Tran N et al: Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 2006;25:135.
16. Calin GA, Liu CG, Ferracin M et al: Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007;12:215.
17. Lin R, Maeda S, Liu C et al: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007;26:851.
18. Bussemakers MJ, Van Bokhoven A, Verhaegh GW et al: DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999;59:5975.
19. Ji P, Diederichs S, Wang W et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage nonsmall cell lung cancer. Oncogene 2003;22:8031.
20. Lai MC, Yang Z, Zhou L et al: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012;29:1810.
21. Tano K, Mizuno R, Okada T et al: MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010;584:4575.
22. Yamada K, Kano J, Tsunoda H et al: Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci 2006;97:106.
23. Xu C, Yang M, Tian J et al: MALAT-1: a long noncoding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol 2011;39:169.
24. Liang CC, Park AY and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocols 2007;2:329.
25. Hawcroft G, Ko CW and Hull MA: Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene 2007;26:3006.
26. Tseng JJ, Hsieh YT, Hsu SL et al: Metastasis associated lung adenocarcinoma transcript 1 is up-regulated in placenta previa increta/percreta and strongly associated with trophoblast-like cell invasion in vitro. Mol Hum Reprod 2009;15:725.
27. Gupta RA, Shah N, Wang KC et al: Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071.
28. Prensner JR and Chinnaiyan AM: The emergence of lncRNAs in cancer biology. Cancer Discov 2011;1:391.
29. Gutschner T, Hämmerle M and Diederichs S: MALAT1da paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013;91:791.